Taís Daiene Russo Hortencio

Taís Daiene Russo Hortencio

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2015 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
PDF file
THTaís Daiene Russo Hortencio
Taís Daiene Russo Hortencio
BABianca Maria Arendt
Bianca Maria Arendt
ATAnastasia Teterina
Anastasia Teterina
KJKhursheed N. Jeejeebhoy
Khursheed N. Jeejeebhoy
LGLeah M. Gramlich
Leah M. Gramlich
JAJohane Allard
Johane Allard

8 August 2012 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
FMFernando Augusto Lima Marson
Fernando Augusto Lima Marson
CBCarmen S Bertuzzo
Carmen S Bertuzzo
THTaís Daiene Russo Hortencio
Taís Daiene Russo Hortencio
JRJosé D Ribeiro
José D Ribeiro
LBLuciana C Bonadia
Luciana C Bonadia
ARAntônio F Ribeiro
Antônio F Ribeiro
Cystic Fibrosis (CF) is a monogenic disease with complex expression because of the action of genetic and environmental factors. We investigated whether the ACE gene D/I polymorphism is associated with severity of CF.

15 January 2015 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
CGCYFIUC Group
CYFIUC Group
FMFernando Augusto Lima Marson
Fernando Augusto Lima Marson
THTaís Daiene Russo Hortencio
Taís Daiene Russo Hortencio
KAKatia Cristina Alberto Aguiar
Katia Cristina Alberto Aguiar
JRJose Dirceu Ribeiro
Jose Dirceu Ribeiro
In recent years, patients with cystic fibrosis (CF) have tended to experience a longer life expectancy and higher quality of life. In this context, the aim of the present study was to evaluate and compare the demographic, clinical, and laboratory markers of patients with CF during the last two decades at a CF referral center. A retrospective study of the demographic, clinical, and laboratory markers for CF treatment at a CF referral center was performed during two decades: 2000 (DI, 1990–2000, n = 104 patients) and 2010 (DII, 2000–2010, n = 181 patients). The following variables were less common in DI than in DII: (i) pancreatic insufficiency, (ii) meconium ileus, (iii) diabetes mellitus, (iv) Burkholderia cepacia colonization, (v) moderate and severe Shwachman-Kulczycki score (SKS), (vi) F508del mutation screening, (vii) patients without an identified CFTR mutation (class IV, V, or VI mutation), (viii) patients above the 10th percentile for weight and height, (ix) restrictive lung disease, and (x) older patients (p < 0.01). The following variables were more common in DI than in DII: (i) excellent and good SKS, (ii) F508del heterozygous status, (iii) colonization by mucoid and nonmucoid Pseudomonas aeruginosa, (iv) obstructive lung disease, and (v) minimal time for CF diagnosis (p < 0.01). Clinical outcomes differed between the two decades. Demographic, clinical, and laboratory markers in patients with CF are useful tools and should be encouraged in CF referral centers to determine the results of CF management and treatment, enabling a better understanding of this disease and its clinical evolution. Early diagnosis and management of CF will improve patients’ quality of life and life expectancy until personalized drug therapy is possible for all patients with CF.

11 February 2016 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
THTaís Daiene Russo Hortencio
Taís Daiene Russo Hortencio
RNRoberto José Negrao Nogueira
Roberto José Negrao Nogueira
FMFernando Augusto Lima Marson
Fernando Augusto Lima Marson
ARAntonio Fernando Ribeiro
Antonio Fernando Ribeiro

1 September 2021 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
ASAlice Missagia de Mattos Springer
Alice Missagia de Mattos Springer
THTaís Daiene Russo Hortencio
Taís Daiene Russo Hortencio
EMErica Carolina Melro
Erica Carolina Melro
TSTiago Henrique de Souza
Tiago Henrique de Souza
RNRoberto José Negrão Nogueira
Roberto José Negrão Nogueira

1 March 2015 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
THTaís Daiene Russo Hortencio
Taís Daiene Russo Hortencio
RNRoberto José Negrão Nogueira
Roberto José Negrão Nogueira
FMFernando Augusto Lima Marson
Fernando Augusto Lima Marson
GHGabriel Hessel
Gabriel Hessel
JRJosé Dirceu Ribeiro
José Dirceu Ribeiro
ARAntônio Fernando Ribeiro
Antônio Fernando Ribeiro
The aim of this study was to evaluate by clinical and laboratory parameters how cystic fibrosis (CF) affects growth and nutritional status of children who were undergoing CF treatment but did not receive newborn screening. A historical cohort study of 52 CF patients younger than 10 years of age were followed in a reference center in Campinas, Southeast Brazil. Anthropometric measurements were abstracted from medical records until March/2010, when neonatal screening program was implemented. Between September/2009 and March/2010, parental height of the 52 CF patients were also measured. Regarding nutritional status, four patients had Z-scores ≤ -2 for height/age (H/A) and body mass index/age (BMI/A). The following variables were associated with improved H/A ratio: fewer hospitalizations, longer time from first appointment to diagnosis, longer time from birth to diagnosis and later onset of respiratory disease. Forced vital capacity [FVC(%)], forced expiratory flow between 25-75% of FVC [FEF25-75(%)], forced expiratory volume in the first second [FEV1(%)], gestational age, birth weight and early respiratory symptoms were associated with IMC/A. Greater number of hospitalizations, diagnosis delay and early onset of respiratory disease had a negative impact on growth. Lower spirometric values, lower gestational age, lower birth weight, and early onset of respiratory symptoms had negative impact on nutritional status. Malnutrition was observed in 7.7% of cases, but 23% of children had nutritional risk.